Vaccination for Children of H&O and Their Parents

Launched by CHILDREN'S CANCER GROUP, CHINA · Dec 13, 2017

Keywords

ClinConnect Summary

This clinical trial is looking at how well a vaccination works for children with certain types of cancer, like blood cancers and solid tumors, as well as for their parents. The main goals are to see how safe the vaccine is and how likely it is that people will get vaccinated. The study is currently recruiting participants, and it includes children aged 18 years and younger who have received specific cancer treatments like chemotherapy or stem cell transplants, as long as they do not have certain health issues that could affect their immune system.

To participate, children must not have had hepatitis B or measles and should be in a stable condition after their cancer treatment. Unfortunately, children who are still very sick or who did not respond well to treatment cannot join. If you decide to participate, you can expect to receive the vaccination and have your health and safety monitored throughout the study. This trial is important because it aims to improve vaccination strategies for young cancer patients and their families.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Children patients(≤18 years) who accepted chemotherapy, hematopoietic stem cell transplantation or splenectomy since our study started.
• • 2. No history of hepatitis B and measles, do not suffer from other diseases that affect immune function and allergic diseases.
• Exclusion Criteria:
• • 1. Children patients who did not reach clinical remission after treatment, critically ill or eventually died.
• • 2. Patients who used monoclonal antibodies, especially anti-tumor necrosis factors.
• • 3. Intermittent or low-dose chemotherapy or other immunosuppressive drugs users.